While most thyroid cancers (TC) are found at early stages and carry excellent outcomes, a small but clinically important group presents with advanced disease. U.S. population data from the SEER program show that about 3% of thyroid cancers are diagnosed with distant metastases, and the 5-year relative survival in this distant stage is ~50% [1]. For context, 64% of cases are localized at diagnosis, and 30% have regional spread – underscoring how different stage 4 disease behaves compared with earlier stages. Patients with advanced thyroid cancer need rapid, specialized care, that is highlighted by these figures.
Understanding Stage 4 Thyroid Cancer
The most advanced phase of the disease is stage 4 thyroid cancer (S4TC). The tumor extends beyond the thyroid gland or spreads to distant organs. At this stage, the cancer behaves very differently from earlier forms – growing more aggressively – and requires complex, multidisciplinary care.
Stage 4A vs Stage 4B
Within this advanced stage, T4, there are two key distinctions:
- Stage 4A usually means the tumor has grown into surrounding tissues in the neck and possibly spread to regional lymph nodes, but without confirmed distant metastases. Patients in this group may still benefit from aggressive surgical resection combined with adjuvant treatment methods.
- Stage 4B is more severe, involving extensive local invasion or confirmed metastases to organs such as the lungs, bones, or liver. In this case, the disease is considered systemic, and the approach shifts toward targeted therapies, external beam radiotherapy, or clinical research options.
These categories define how doctors plan therapy and explain thyroid cancer stage 4 prognosis. For patients seeking advanced care, understanding the difference between stage 4A and 4B is often the first step in navigating modern methods available in German clinics.
Types of Stage 4 Thyroid Cancer
Not all cancers behave the same way. Stage 4 disease can occur in:
- Papillary and follicular thyroid cancer (differentiated types), PTC and FTC– usually slow-growing, but advanced cases may spread to the lungs or bones.
- Medullary thyroid cancer, MTC–a rarer type, sometimes it is hereditary; it tends to spread to lymph nodes and distant organs.
- Anaplastic thyroid cancer, ATC– the most aggressive and difficult-to-treat form, almost always diagnosed at stage 4.
Symptoms and Diagnosis
By the time cancer reaches stage 4, the symptoms usually become more noticeable and often interfere with daily life. Unlike earlier stages, patients experience problems not only from the tumor itself but also from its spread to other organs. Recognizing these warning signs and undergoing timely diagnostic procedures is essential, since both the choice of treating thyroid cancer and the expected cancer stage 4 prognosis depend heavily on accurate staging.
Symptoms of Stage 4 Thyroid Cancer
Typical complaints at this stage include:
- Breathing difficultieswhen the tumor compresses or invades the trachea
- Hoarseness or voice changescaused by involvement of the recurrent laryngeal nerve
- Persistent cough or swallowing problemsdue to esophageal compression
- Neck pain or a visible mass,sometimesaccompanied by swollen lymph nodes
- Metastatic symptoms,such as bone pain, fractures, or shortness of breath, if the lungs are affected
These symptoms often prompt patients to seek specialized oncology services, where advanced imaging and laboratory tests can confirm the diagnosis.
How Diagnosis of Stage 4 Thyroid Cancer is Made
Confirmation of advanced thyroid malignancy is a challenging task. How do German medical centers achieve diagnostic accuracy? Through a multi-modal strategy. It integrates clinical assessment and complementary methodologies – ultrasound, biopsy, advanced scanning, and biomarker evaluation:
- Ultrasound (US):the first-line method; it allows evaluate the thyroid gland and cervical lymph nodes. US helps detect tumor size and borders, nodal involvement.
- Fine-needle aspiration biopsy (FNA):this is a procedure for tissue sampling – it remains the gold standard for confirming cancer and determining its histological type to plan a treatment scheme more carefully.
- PET-CT scansare particularly valuable in iodine-negative cases. PET-CT can reveal metastases in the lungs, bones, or liver.
- Blood tests:thyroglobulin (for differentiated cancers) or calcitonin (for medullary TCa) provide important information for staging and follow-up. Thyroid antibodies do not necessarily need to be tested.
Diagnostic pathways involve coordinated evaluation by endocrinologists, surgical oncologists, nuclear medicine physicians, and medical oncologists, due to the multifactorial nature of advanced disease. This integrated approach enables refined diagnosis accuracy – particularly critical when addressing metastatic presentations.
Thyroglobulin for differentiated cancers and calcitonin for medullary thyroid carcinoma are not only diagnostic markers — they are the biomarkers the German team will use to monitor treatment response after therapy begins. A patient whose records include historical thyroglobulin values but no recent measurement arrives without the baseline the German nuclear medicine team needs to assess whether RAI has been effective or whether targeted therapy has changed the disease trajectory.
Booking Health's case preparation identifies which biomarker measurements are present and current, and ensures the complete laboratory history is forwarded in translated, organized form before the multidisciplinary diagnostic review.
CHECK IF A BETTER SOLUTION EXISTS FOR YOUStandard Treatment Methods for Thyroid Cancer Stage 4 in Germany
Multidisciplinary approach is applied during stage 4 thyroid cancer treatment in Germany. Depending on the case, the scheme may include thyroid surgery, nuclear medicine approaches, systemic therapy, and immunological strategies. German oncology institutions use internationally recognized protocols that combine evidence-based methodologies with patient-specific local modifications.
Surgical Intervention For Thyroid Cancer
Thyroid surgery is the basic treatment method. This involves the removal of the primary tumor and affected lymph nodes (lymph node metastases, N1), followed by lifelong hormone therapy as thyroid hormone production stops. The main goal is 一 to physically remove the maximum number of tumor cells. This allows to reduce the tumor burden and prevents its further spread. In anaplastic or advanced TCa, complete removal is often impossible as the tumor invades surrounding tissues, blood vessels, or critical organs.
To make the intervention minimally traumatic and minimize the risks of postoperative complications [8], doctors in Germany use the following surgical interventions:
- Endoscopic interventions — gland removal through small punctures in the neck using endoscopic instruments. The accuracy of the procedure is ensured by image guidance using a miniature camera.
- Robot-assisted surgery — surgical removal of an organ using robotic technology. The intervention is performed by a robot, while a doctor controls the manipulations.
The amount of tissue removed depends on the type of thyroid tumor. Total thyroidectomy (TT) is the basic option. But, for example, in the case of papillary and follicular cancer, surgeons try to remove only a part of the lymph nodes to avoid complications and reduce hormone therapy doses. The resection is followed by radioiodine therapy, which destroys the remaining metastases. This example highlights the role of endocrine surgery in Germany in managing complex cases, a topic Professor Fendrich discusses in detail in the video below.
The surgical decision between total thyroidectomy and more limited resection — and whether robotic or endoscopic approach is appropriate — depends on current neck imaging that maps the tumor's relationship to the trachea, esophagus, recurrent laryngeal nerve, and carotid artery.
For a patient whose tumor has progressed since their most recent scan, the surgical plan that the German team would have designed from older imaging may be the wrong plan for the anatomy they actually encounter in the operating room.
Booking Health identifies whether current high-resolution neck MRI and CT are available before the surgical consultation is scheduled, so the endocrine surgeon's first assessment of resectability is made from confirmed current anatomy.
Radioactive Iodine Therapy (RAI)
Radioactive iodine therapy in Germany is a hallmark of TCr care. After surgery, RAI is used to destroy residual thyroid tissue and microscopic tumor deposits. In stage 4, this therapy can be highly effective in eliminating metastases that remain iodine-avid. German nuclear medicine departments are among the best equipped worldwide, providing repeated cycles with precise dosimetry. For patients with advanced thyroid cancer therapy needs, radioactive iodine therapy in Germany also plays a central role in long-term disease control, especially in differentiated thyroid carcinomas. In total, radioactive iodine therapy in Germany represents one of the most reliable and widely applied systemic strategies in managing advanced TCa.
Chemotherapy for Stage 4 Thyroid Cancer
Chemotherapy is used mainly for aggressive forms of thyroid carcinoma 一 such as anaplastic cancer or in the presence of distant metastases. Сhemo acts via cytotoxic drugs that target tumor cells. Drugs affect their ability to divide and induce cell death. Unfortunately, at the same time, affects normal cells with a high division rate, which leads to the development of side effects.
Limitations of classical chemotherapy can be severe. These are toxicity, suppression of the immune system, poor efficacy in resistant cancers, and the need for careful monitoring of the patient's condition.
Problems and Limitations of the Conventional Approaches
At stage 4 cancer, standard methods are not always capable of destroying tumor cells and controlling metastases. Aggressive forms of cancer (anaplastic and medullary cancer) are often resistant to surgery, radioactive iodine therapy and chemotherapy. Side effects of classical methods, reduced immune function and drug dosage limitations create additional difficulties for patients. Therefore, an individualized treatment plan that combines standard methods with modern strategies for maximum effectiveness is especially important at this stage.
Advanced Treatment Methods in Germany for Stage 4 Thyroid Cancer
For patients with stage 4 cancer, standard regimens often do not provide long-term remission. That is why German clinics are actively implementing innovative methods that allow for targeted action on cancer cells. Modern medicine in Germany combines targeted therapy, dendritic cell therapy and other personalized strategies, which create new opportunities even for patients with advanced tumors.
Targeted Therapy For Thyroid Cancer
In the case of anaplastic and medullary thyroid carcinomas, targeted therapy shows promising results: it helps to stop the progression of the disease, reduce the volume of the tumor and improve the prognosis. This is achieved by affecting the VEGF, RET or BRAF receptors, which regulate the reproduction of tumor cells [6].
Targeted therapy is aimed at molecular targets that control the growth and division of cancer cells [7]. Its mechanism of action is based on blocking the signaling pathways that trigger proliferation and angiogenesis. Unlike chemotherapy, targeted drugs do not destroy all cells, but selectively act on those with specific mutations.
The doctors in Germany use several groups of drugs that are selected individually. These include:
- Multikinase inhibitorsare drugs that simultaneously block several types of protein molecules in cancer cells. They act using two mechanisms: they suppress the activity of proteins involved in the growth of abnormal cells and inhibit the formation of new vessels required for the blood supply to a malignant tumor. Multikinase inhibitors are available in the form of pills.
- RET inhibitorsare used in the presence of changes in the RET gene to block specific molecules involved in the multiplication of cancer cells. Therapy with such drugs can be used for stage 4 cancer of papillary or follicular types if radioiodine therapy is ineffective. RET inhibitors are taken in capsules, 2 times a day.
- NTRK inhibitorsare used in the presence of mutations in the corresponding gene. These drugs have been recently introduced into clinical practice — they were approved in Europe in 2019. They are usually prescribed when other options do not give any results. The drugs are taken in the form of pills.
- BRAF and MEK inhibitorsare used for anaplastic thyroid cancer, which has limited options. The drugs block molecules responsible for the division of cancer cells.
In leading German clinics, patients with thyroid cancer are given an individual treatment plan depending on the type of mutations and the sensitivity of the tumor. This allows for greater effectiveness even in advanced stages and distant metastases.
Dendritic Cell Therapy
Among the most innovative methods in stage 4 thyroid cancer treatment in Germany is the use of dendritic cells [10]. These immune cells act as the "teachers" of the immune system, capturing tumor antigens and presenting them to T-cells. When dendritic cells are collected from a patient, activated in the laboratory with tumor-specific antigens, and then reinfused, they essentially reprogram the immune system to recognize and destroy cancer cells more effectively.
The significance of dendritic cells in medicine was recognized on the global stage when the discovery of their role in adaptive immunity earned a Nobel Prize in Physiology or Medicine in 2011 [5]. Building on this foundation, German oncology centers have turned dendritic cell vaccination into a practical component of advanced cancer therapy, with clinical results showing improved disease control in patients who had few alternatives left.
For an expert introduction to dendritic cell-based cancer immunotherapy in Germany—its biological principle, therapeutic potential, and place in contemporary oncology—see interview with Prof. Dr. Gansauge.
VIDEO
Prof. Frank Gansauge: How Dendritic Cell Therapy is Transforming Modern Cancer Treatment
Dendritic Cell Therapy
BOOK CONSULTATION
For patients with radioiodine-refractory differentiated thyroid cancer — the subgroup where RAI has been attempted and failed and standard targeted therapy has not produced durable response — DC vaccination represents one of the few remaining approaches that does not depend on iodine avidity or a specific kinase mutation.
The antigen loading that makes the vaccine effective, however, requires current tumor material: a thyroid cancer patient whose primary tumor was removed years ago and whose disease now consists of distant metastases needs antigen sourcing from the metastatic lesions rather than from the original histological specimen.
Booking Health's pre-treatment case review assesses whether current biopsy or liquid biopsy material is available to serve as the antigen source before the German center's vaccine preparation protocol is confirmed.
GET A SECOND OPINION FOR MY CASEEmbolization of Metastases
Metastases can be surgically removed in only a small number of patients. Therefore, to destroy metastatic foci, hospitals often give preference to a minimally invasive procedure for cancer treatment in Germany called embolization. The essence of the technique is that the doctor blocks the vessels providing blood supply to the tumor with emboli – chemicals. The last ones are injected into the arteries. As a result, the tumor tissues do not receive enough oxygen and quickly die [9].
The procedure does not require open surgery. The doctor makes a small incision in the skin and then inserts a catheter into the arterial bed. A contrast agent is used to detect the vessels supplying the tumor. Then the arteries are blocked by emboli, which stop the blood supply to the tumor. The procedure is performed under X-ray guidance. This makes minimally invasive cancer treatment in Germany a safe and effective alternative to surgery.
Recently, for thyroid cancer stage 4, Germany has been increasingly using transarterial chemoembolization (TACE). This type uses microspheres with anticancer drugs. Medications are released in doses over several weeks after the procedure, affecting only the pathological focus. Chemoembolization in stage 4 cancer treatment in Germany damages cancer cells and prevents the growth of metastases.
Embolization techniques continue to expand. Doctors now rely on more precise materials, better imaging, and selective catheterization to control metastatic disease. A clear overview of how these methods work in real practice is presented in interview with Prof. Dr. Attila Kovács.
VIDEO
Prof. Kovács: When to Use DEB-TACE, Conventional TACE, or Radioembolization (TARE)
Interventional Radiology
BOOK CONSULTATION
Comparative Table: Methods for Stage 4 Thyroid Cancer
Based on Booking Health clinical data and published outcomes. Actual results may vary depending on patient's condition and the protocol.
| Therapy Type | 2-Year Survival Rate | Response Rate | Duration | Side Effects |
|---|---|---|---|---|
| Standard Options | ~55-70% for early stages ~30% for advanced stages | ~40-60% | Several weeks to months | Moderate to severe (fatigue, nausea, infertility, bowel/bladder issues) |
| Innovative Methods | ~60-75% in select advanced/refractory cases | 45-65% | Multiple sessions are possible | Mild (fever, localized inflammation, flu-like symptoms) |
Why Choose Treatment in Germany?
For many patients worldwide, from countries with different Human Development Index (HDI), cancer care in Germany means access to innovative equipment for high-quality diagnostics, specialized surgeons and innovative therapies, international standards. Choosing treatment in Germany offers both technical expertise and personalized disease care that aligns with each patient’s unique profile.
Advanced Multidisciplinary Care
Multiple specialties' involvement defines the approach of German hospitals for thyroid cancer treatment. Endocrinologists, surgeons, nuclear medicine specialists, oncologists, and immunologists – all collaborate here closely. Every step is coordinated. These ensure that patients receive the most effective combination of therapeutic methods.
Innovative Technology and Therapies
Cancer treatment in Germany is defined by the availability of modern technologies that are not yet widely accessible elsewhere. Imaging, minimally invasive surgery, precision radiation therapy – radioiodine therapy, and advanced molecular testing all contribute to a higher standard of care. Patients can access therapies like dendritic cell vaccination and advanced targeted agents in fully equipped centers, where every intervention is backed by scientific evidence. Because innovation is baked into daily practice, care for thyroid cancer in Germany relies on methods proven to extend survival – not on experimental add-ons.
Comprehensive Patient Support
International medical travel presents logistical challenges. Booking Health addresses these systematically: consultation arrangements, treatment scheduling, accommodation coordination, translation services, insurance management – all handled to ensure seamless experience. German hospitals maintain dedicated international patient departments. Support teams minimize administrative burden so focus remains on recovery.
Proven Outcomes and Expertise
Excellent clinical results characterize cancer treatment in Germany, even in complex stage 4 presentations. This is achieved through the combination of high number of patients, subspecialty expertise, and access to innovative therapies. Every disease aspect is carefully managed here. In addition, follow-up protocols and long-term care ensure continuity and stable results.
Advanced Healthcare Facilities
European hospitals also pay due attention to rehabilitation after the completion of the main course of treatment for the full recovery of patients. The leading German hospitals that demonstrate the highest success rates in the treatment of advanced thyroid cancer are:
- Martha-Maria Hospital Munich, Department of General and Abdominal Surgery, Hernia Surgery, Endocrine Surgery, Thoracic Surgery
- University Hospital Ulm, Department of General and Abdominal Surgery
- University Hospital Marburg UKGM, Department of Abdominal, Thoracic and Vascular Surgery
- University Hospital Carl Gustav Carus Dresden, Department of Abdominal and Colorectal Surgery, Hepatobiliary Surgery, Hernia Surgery, Bariatric Surgery, Endocrine Surgery, Thoracic and Vascular Surgery
You can find the detailed and updated information about these and other hospitals on the Booking Health website.
Cost of Thyroid Cancer Treatment Abroad
| Treatment Method | Mechanism of Action | Advantages | Cost |
|---|---|---|---|
| Targeted Therapy | Blocks specific molecular pathways (e.g., BRAF, RET, VEGF) to inhibit tumor growth and angiogenesis | Highly selective, less systemic toxicity than chemotherapy, can control thyroid tumors progression | €375,000 - €420,000 in Germany €400,000 - €500,000 in Great Britain €600,000 - €1,000,000 in the USA |
| Dendritic Cell Therapy | Activates patient’s immune system to recognize and destroy tumor cells via antigen presentation | Induces long-term immune memory, can target metastases | €20,000 - €38,000 in Germany Not available in Great Britain €100,000 - €150,000 in the USA |
| Embolization / TACE | Blocks blood supply to metastases, sometimes combined with local delivery of cytotoxic drugs | Minimally invasive, preserves surrounding tissue, reduces thyroid tumors size | €6,500 - €24,000 in Germany €25,000 - €45,000 in Great Britain €40,000 - €100,000 in the USA |
| Radiation therapy – radioiodine therapy (RAI) | During radioiodine therapy, radioactive iodine is absorbed by thyroid cells and metastatic tumor cells, causing DNA damage and cell death | Radioiodine therapy selectively targets thyroid nodules with tumor cells, minimal effect on healthy tissue | €16,900 - €17,600 in Germany |
Germany's DC therapy figures represent the sharpest availability gap in this table — not available in the UK at any price, and five times more expensive in the US. For British patients with radioiodine-refractory disease who have exhausted targeted therapy options, Germany is not the affordable choice: it is the only choice.
Patients coordinating through Booking Health access Germany's prices without the foreign patient surcharge that clinics apply. In addition, complication insurance of €200,000 is included as standard, and unspent funds are returned after the program concludes.
FIND THE RIGHT SPECIALIST FOR MY CASEA Medical Journey: Every Step of the Way With Booking Health
Finding the best treatment strategy for your clinical situation is a challenging task. Being already exhausted from multiple treatment sessions, having consulted numerous specialists, and having tried various therapeutic interventions, you may be lost in all the information given by the doctors. In such a situation, it is easy to choose a first-hand option or to follow standardized therapeutic protocols with a long list of adverse effects instead of selecting highly specialized innovative treatment options.
To make an informed choice and get a personalized cancer management plan, which will be tailored to your specific clinical situation, consult medical experts at Booking Health. Being at the forefront of offering the latest medical innovations for already 12 years, Booking Health possesses solid expertise in creating complex management programs in each individual case. As a reputable company, Booking Health offers personalized stage 4 thyroid cancer treatment plans with direct clinic booking and full support at every stage, from organizational processes to assistance during treatment.
We provide:
- Assessment and analysis of medical reports
- Development of the medical care program
- Selection of a suitable treatment location
- Preparation of medical documents and forwarding to a suitable clinic
- Preparatory consultations with clinicians for the development of medical care programs
- Expert advice during the hospital stay
- Follow-up care after the patient returns to their native country after completing the medical care program
- Taking care of formalities as part of the preparation for the medical care program
- Coordination and organization of the patient's stay in a foreign country
- Assistance with visas and tickets
- A personal coordinator and interpreter with 24/7 support
- Transparent budgeting with no hidden costs
Health is an invaluable aspect of our lives. Delegating management of something so fragile yet precious should be done only to experts with proven experience and a reputation. Booking Health is a trustworthy partner who assists you in pursuing stronger health and a better quality of life. Contact our medical consultant to learn more about the possibilities of personalized treatment with innovative methods for stage 4 thyroid cancer with leading specialists in this field.
Booking Health holds ISO 9001 quality certification, reflecting well-established processes and strict quality control at every stage of the treatment journey — not just at the initial consultation, but throughout.
Modern Cancer Treatment: Patient Journeys with Booking Health
FAQ: Stage 4 Thyroid Cancer Treatment In Germany
Stage 4 thyroid cancer is diagnosed when the disease spreads beyond the thyroid gland itself – involving regional lymph nodes, distant organs, or both.
Yes. German medical centers offer comprehensive therapeutic strategies combining advanced surgical techniques, radiation therapy with radioactive iodine, targeted therapy, and modern immunotherapeutic approaches for stage 4 thyroid cancer treatment.
Visible or palpable neck lump, persistent voice changes, pain when swallowing, and swallowing difficulty may be stage 4 thyroid cancer symptoms. Breathing problems may occur due to tumor growth or spread as disease progresses.
Advanced surgery, radiation therapy with radioactive iodine, precision drugs, and personalized immune-based therapies are used in German healthcare facilities – integrated in different treatment strategies.
The price depends on the care plan, type of surgery, drugs, and length of hospital stay. You can check costs on the Booking Health website.
Patients can choose among clinics known for endocrine oncology and nuclear medicine. You will find the list of suitable hospitals on the Booking Health website.
Booking Health services include full medical coordination, expert clinic selection, translation, and assistance with documents. The platform helps patients navigate German healthcare, ensuring smooth access to leading specialists and effective treatment abroad.
The patient's chances depend heavily on how thyroid cancer is diagnosed and treated. With advanced stage 4 thyroid cancer treatment in Germany many patients achieve prolonged remission.
Life expectancy depends on cancer type and therapy response. You will hear your personal disease prognosis from your physician, after the assessment and therapy start. Adherence to treatment and following all recomendations improve the prognosis.
Surgery, radiation therapy – radioiodine therapy, targeted therapy, and dendritic cell vaccination are treatment options for thyroid cancer in Germany. Personalized strategies that patients benefit from most are used here.
The treatment cost for thyroid cancer in Germany varies with clinical complexity. The cost of advanced thyroid cancer therapy depends on diagnosis, treatment and postoperative care. Booking Health helps optimize expenses and hospital selection.
German oncology centers apply these modern approaches to control advanced disease. Yes, targeted therapy for thyroid cancer – especially combined with dendritic cell immunotherapy – can suppress tumor progression and enhance survival.
Each international patient thyroid cancer in Germany program offers multidisciplinary expertise, advanced technology, and individualized care. German hospitals are globally recognized for precision oncology and success in managing late-stage thyroid cancer.
Complete cure is rare. But a thyroid cancer 4-stage diagnosis doesn’t mean hopelessness. With advanced medical care in Germany, many patients can achieve stable disease control.
Targeted therapy works by blocking specific molecular pathways that control tumor growth and angiogenesis. This allows selective action on cancer cells and minimal systemic toxicity – properties that cancer patients benefit from.
Dendritic cell therapy activates the patient’s immune system to recognize and destroy tumor cells. Treatment method is particularly useful in immunotherapy for thyroid cancer advanced cases, where standard options are limited.
Embolization or transarterial chemoembolization (TACE) is an endovascular procedure in the sphere of interventional radiology. It blocks blood supply to metastases – in the liver or other sites – and delivers cytotoxic drugs locally.
Choose treatment abroad and you will be sure to get the best results!
Sources:
01. National Cancer Institute. Cancer Stat Facts: Thyroid Cancer https://seer.cancer.gov/statfacts/html/thyro.html
02. Michelle Carnazza, Danielle Quaranto, Nicole DeSouza et al. The Current Understanding of the Molecular Pathogenesis of Papillary Thyroid Cancer. Int J Mol Sci. 2025 May 13;26(10):4646. doi: 10.3390/ijms26104646. [DOI] [PubMed]
03. Ivana Puliafito, Francesca Esposito, Angela Prestifilippo et al. Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects. Front Endocrinol (Lausanne). 2022 Jul 8;13:860671. doi: 10.3389/fendo.2022.860671. [DOI] [PMC free article]
04. Sarah Hamidi, Marie-Claude Hofmann, Priyanka C Iyer, Maria E Cabanillas et al. Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front Endocrinol (Lausanne). 2023 Jun 26;14:1176731. doi: 10.3389/fendo.2023.1176731. [DOI] [PMC free article]
05. Nobel Prize. The Nobel Prize in Physiology or Medicine 2011 – Ralph Steinman. https://www.nobelprize.org/prizes/medicine/2011/steinman/facts/
06. Sara Gil-Bernabé, Lucía García-DeLaFuente, Ginesa García-Rostán et al. The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs. Int J Mol Sci. 2025 Apr 12;26(8):3663. doi: 10.3390/ijms26083663. [DOI] [PMC free article]
07. Ivana Puliafito, Francesca Esposito, Angela Prestifilippo et al. Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects. Front Endocrinol (Lausanne). 2022 Jul 8;13:860671. doi: 10.3389/fendo.2022.860671. [DOI] [PMC free article]
08. Lisa H. de Vries, Dilay Aykan, Lutske Lodewijk et al. Outcomes of Minimally Invasive Thyroid Surgery – A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:719397. doi:10.3389/fendo.2021.719397. [DOI]
09. S Grozinsky-Glasberg, A I Bloom, N Lev-Cohain et al. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature. European Journal of Endocrinology, Volume 176, Issue 4, Apr 2017, Pages 463–470. doi:10.1530/EJE-16-0960. [DOI]
10. Anton Stift, Monika Sachet, Rubina Yagubian et al. Dendritic Cell Vaccination in Medullary Thyroid Carcinoma. Clin Cancer Res (2004) 10 (9): 2944–2953. doi:10.1158/1078-0432.CCR-03-0698. [DOI]
Read:
01. Effective Thyroid cancer Treatment
